The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.
Anaplastic lymphoma kinase: signalling in development and disease
Open accessAbstract
RTKs (receptor tyrosine kinases) play important roles in cellular proliferation and differentiation. In addition, RTKs reveal oncogenic potential when their kinase activities are constitutively enhanced by point mutation, amplification or rearrangement of the corresponding genes. The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma). To date, many chromosomal rearrangements leading to enhanced ALK activity have been described and are implicated in a number of cancer types. Recent reports of the EML4 (echinoderm microtubule-associated protein like 4)–ALK oncoprotein in NSCLC (non-small cell lung cancer), together with the identification of activating point mutations in neuroblastoma, have highlighted ALK as a significant player and target for drug development in cancer. In the present review we address the role of ALK in development and disease and discuss implications for the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Müller, M., Regenass, U., & Lydon, N. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2558 · Cited by 270
RetractedEGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,490
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020461 · Cited by 4,389
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
Trastuzumab — Mechanism of Action and Use in Clinical Practice
Hudis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra043186 · Cited by 2,585
Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., & Look, A. T. (1994) · Science · doi:10.1126/science.8122112 · Cited by 2,409
Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer
Rikova, K., Guo, A., Zeng, Q., Possemato, A., Yu, J., Haack, H., Nardone, J., Lee, K., Reeves, C., Li, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.11.025 · Cited by 2,317
Neuroblastoma: biological insights into a clinical enigma
Brodeur, G. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1014 · Cited by 2,160
Joensuu, H., Roberts, P. J., Sarlomo-Rikala, M., Andersson, L. C., Tervahartiala, P., Tuveson, D., Silberman, S. L., Capdeville, R., Dimitrijevic, S., Druker, B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441404 · Cited by 2,037
Maris, J. M., Hogarty, M. D., Bagatell, R., & Cohn, S. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60983-0 · Cited by 2,032
Stein, H., Mason, D., Gerdes, J., O'Connor, N., Wainscoat, J., Pallesen, G., Gatter, K., Falini, B., Delsol, G., Lemke, H., et al. (1985) · Blood · doi:10.1182/blood.v66.4.848.848 · Cited by 1,846
Identification of ALK as a major familial neuroblastoma predisposition gene
Mossé, Y. P., Laudenslager, M., Longo, L., Cole, K. A., Wood, A., Attiyeh, E. F., Laquaglia, M. J., Sennett, R., Lynch, J. E., Perri, P., et al. (2008) · Nature · doi:10.1038/nature07261 · Cited by 1,407
Buchdunger, E., Cioffi, C. L., Law, N., Stover, D., Ohno-Jones, S., Druker, B. J., & Lydon, N. B. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38879-2 · Cited by 1,274
van Oosterom, A. T., Judson, I., Verweij, J., Stroobants, S., di Paola, E. D., Dimitrijevic, S., Martens, M., Webb, A., Sciot, R., Van Glabbeke, M., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06535-7 · Cited by 1,264
Jemal, A., Clegg, L. X., Ward, E., Ries, L. A. G., Wu, X., Jamison, P. M., Wingo, P. A., Howe, H. L., Anderson, R. N., & Edwards, B. K. (2004) · Cancer · doi:10.1002/cncr.20288 · Cited by 1,140
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells
Rush, J., Moritz, A., Lee, K. A., Guo, A., Goss, V. L., Spek, E. J., Zhang, H., Zha, X.-M., Polakiewicz, R. D., & Comb, M. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1046 · Cited by 1,124
Role of Tyrosine Kinase Inhibitors in Cancer Therapy
Arora, A., & Scholar, E. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084145 · Cited by 1,014
Coffin, C. M., Hornick, J. L., & Fletcher, C. D. M. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213393.57322.c7 · Cited by 1,006
EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
Koivunen, J. P., Mermel, C., Zejnullahu, K., Murphy, C., Lifshits, E., Holmes, A. J., Choi, H. G., Kim, J., Chiang, D., Thomas, R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0168 · Cited by 993
Stein, H., Foss, H., Dürkop, H., Marafioti, T., Delsol, G., Pulford, K. A. F., Pileri, S. A., & Falini, B. (2000) · Blood · doi:10.1182/blood.v96.12.3681 · Cited by 949
Oncogenic mutations of ALK kinase in neuroblastoma
Chen, Y., Takita, J., Choi, Y. L., Kato, M., Ohira, M., Sanada, M., Wang, L., Soda, M., Kikuchi, A., Igarashi, T., et al. (2008) · Nature · doi:10.1038/nature07399 · Cited by 916
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Janoueix-Lerosey, I., Lequin, D., Brugières, L., Ribeiro, A., de Pontual, L., Combaret, V., Raynal, V., Puisieux, A., Schleiermacher, G., Pierron, G., et al. (2008) · Nature · doi:10.1038/nature07398 · Cited by 894
Activating mutations in ALK provide a therapeutic target in neuroblastoma
George, R. E., Sanda, T., Hanna, M., Fröhling, S., II, W. L., Zhang, J., Ahn, Y., Zhou, W., London, W. B., McGrady, P., et al. (2008) · Nature · doi:10.1038/nature07397 · Cited by 893
Savage, K. J., Harris, N. L., Vose, J. M., Ullrich, F., Jaffe, E. S., Connors, J. M., Rimsza, L., Pileri, S. A., Chhanabhai, M., Gascoyne, R. D., et al. (2008) · Blood · doi:10.1182/blood-2008-01-134270 · Cited by 863
Structure and Function of the Cell Surface (Tethered) Mucins
Hattrup, C. L., & Gendler, S. J. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100659 · Cited by 779
Inflammatory myofibroblastic tumours: where are we now?
Gleason, B. C., & Hornick, J. L. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.049387 · Cited by 757
Zou, H. Y., Li, Q., Lee, J. H., Arango, M. E., McDonnell, S. R., Yamazaki, S., Koudriakova, T. B., Alton, G., Cui, J. J., Kung, P.-P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4443 · Cited by 745
Iwahara, T., Fujimoto, J., Wen, D., Cupples, R., Bucay, N., Arakawa, T., Mori, S., Ratzkin, B., & Yamamoto, T. (1997) · Oncogene · doi:10.1038/sj.onc.1200849 · Cited by 726
Wong, D. W., Leung, E. L., So, K. K., Tam, I. Y., Sihoe, A. D., Cheng, L., Ho, K., Au, J. S., Chung, L., Pik Wong, M., et al. (2009) · Cancer · doi:10.1002/cncr.24181 · Cited by 719
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
Lawrence, B., Perez-Atayde, A., Hibbard, M. K., Rubin, B. P., Dal Cin, P., Pinkus, J. L., Pinkus, G. S., Xiao, S., Yi, E. S., Fletcher, C. D. M., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64550-6 · Cited by 714
Translation of the Philadelphia chromosome into therapy for CML
Druker, B. J. (2008) · Blood · doi:10.1182/blood-2008-07-077958 · Cited by 668
Christensen, J. G., Zou, H. Y., Arango, M. E., Li, Q., Lee, J. H., McDonnell, S. R., Yamazaki, S., Alton, G. R., Mroczkowski, B., & Los, G. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0365 · Cited by 649
Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors.
Griffin, C. A., Hawkins, A. L., Dvorak, C. C., Henkle, C., Ellingham, T. J., & Perlman, E. J. (1999) · PubMed · Cited by 571
ALK+ lymphoma: clinico-pathological findings and outcome.
Falini, B., Pileri, S. A., Zinzani, P. L., Carbone, A., Zagonel, V., Wolf‐Peeters, C. D., Verhoef, G. E. G., Menestrina, F., Todeschini, G., Paulli, M., et al. (1999) · PubMed · doi:10.1182/blood.v93.8.2697 · Cited by 560
Pulford, K. A. F., Lamant, L., Morris, S. W., Butler, L. H., Wood, K. M., Stroud, D., Delsol, G., & Mason, D. Y. (1997) · Blood · doi:10.1182/blood.v89.4.1394 · Cited by 557
Graves, P. R., Yu, L., Schwarz, J. K., Gales, J., Sausville, E. A., O'Connor, P. M., & Piwnica-Worms, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5600 · Cited by 544
Gascoyne, R. D., Aoun, P., Wu, D., Chhanabhai, M., Skinnider, B. F., Greiner, T. C., Morris, S. W., Connors, J. M., Vose, J. M., Viswanatha, D. S., et al. (1999) · Blood · doi:10.1182/blood.v93.11.3913 · Cited by 524
Morris, S. W., Naeve, C., Mathew, P., James, P. L., Kirstein, M. N., Cui, X., & Witte, D. P. (1997) · Oncogene · doi:10.1038/sj.onc.1201062 · Cited by 524
A mouse model for EML4-ALK -positive lung cancer
Soda, M., Takada, S., Takeuchi, K., Choi, Y. L., Enomoto, M., Ueno, T., Haruta, H., Hamada, T., Yamashita, Y., Ishikawa, Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805381105 · Cited by 512
EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers
Inamura, K., Takeuchi, K., Togashi, Y., Nomura, K., Ninomiya, H., Okui, M., Satoh, Y., Okumura, S., Nakagawa, K., Soda, M., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31815e8b60 · Cited by 467
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
Chiarle, R., Simmons, W. J., Cai, H., Dhall, G., Zamo, A., Raz, R., Karras, J. G., Levy, D. E., & Inghirami, G. (2005) · Nature Medicine · doi:10.1038/nm1249 · Cited by 442
Meng, K., Rodríguez-Peña, A., Dimitrov, T., Chen, W., Yamin, M., Noda, M., & Deuel, T. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.020487997 · Cited by 418
Muramatsu, T. (2002) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003231 · Cited by 405
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
Zamo, A., Chiarle, R., Piva, R., Howes, J., Fan, Y., Chilosi, M., Levy, D. E., & Inghirami, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205152 · Cited by 399
McDermott, U., Iafrate, A. J., Gray, N. S., Shioda, T., Classon, M., Maheswaran, S., Zhou, W., Choi, H. G., Smith, S. L., Dowell, L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6186 · Cited by 399
Identification of Anaplastic Lymphoma Kinase as a Receptor for the Growth Factor Pleiotrophin
Stoica, G. E., Kuo, A., Aigner, A., Sunitha, I., Souttou, B., Malerczyk, C., Caughey, D. J., Wen, D., Karavanov, A., Riegel, A. T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010660200 · Cited by 382
Shiota, M., Nakamura, S., Ichinohasama, R., Abe, M., Akagi, T., Takeshita, M., Mori, N., Fujimoto, J., Miyauchi, J., & Mikata, A. (1995) · Blood · doi:10.1182/blood.v86.5.1954.bloodjournal8651954 · Cited by 380
Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK
Galkin, A. V., Melnick, J. S., Kim, S., Hood, T. L., Li, N., Li, L., Xia, G., Steensma, R., Chopiuk, G., Jiang, J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609412103 · Cited by 379
Bischof, D., Pulford, K., Mason, D. Y., & Morris, S. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2312 · Cited by 363
Fusion of the ALK Gene to the Clathrin Heavy Chain Gene, CLTC, in Inflammatory Myofibroblastic Tumor
Bridge, J. A., Kanamori, M., Ma, Z., Pickering, D., Hill, D. A., Lydiatt, W., Lui, M. Y., Colleoni, G. W. B., Antonescu, C. R., Ladanyi, M., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61711-7 · Cited by 359
Stoica, G. E., Kuo, A., Powers, C., Bowden, E. T., Sale, E. B., Riegel, A. T., & Wellstein, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205749200 · Cited by 357
Midkine and pleiotrophin in neural development and cancer
Kadomatsu, K., & Muramatsu, T. (2004) · Cancer Letters · doi:10.1016/s0304-3835(03)00450-6 · Cited by 354
Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module
Fass, D., Blacklow, S., Kim, P. S., & Berger, J. M. (1997) · Nature · doi:10.1038/41798 · Cited by 339
Bai, R.-Y., Ouyang, T., Miething, C., Morris, S. W., Peschel, C., & Duyster, J. (2000) · Blood · doi:10.1182/blood.v96.13.4319 · Cited by 319
EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues
Martelli, M. P., Sozzi, G., Hernandez, L., Pettirossi, V., Navarro, A., Conte, D., Gasparini, P., Perrone, F., Modena, P., Pastorino, U., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080755 · Cited by 317
Cools, J., Włodarska, I., Somers, R., et al. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10033 · Cited by 292
Mitsiadis, T. A., Salmivirta, M., Muramatsu, T., Muramatsu, H., Rauvala, H., Lehtonen, E., Jalkanen, M., & Thesleff, I. (1995) · Development · doi:10.1242/dev.121.1.37 · Cited by 292
Phase I Trial of 72-Hour Continuous Infusion UCN-01 in Patients With Refractory Neoplasms
Sausville, E. A., Arbuck, S. G., Messmann, R., Headlee, D., Bauer, K. S., Lush, R. M., Murgo, A., Figg, W. D., Lahusen, T., Jaken, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2319 · Cited by 291
Fujimoto, J., Shiota, M., Iwahara, T., Seki, N., Satoh, H., Mori, S., & Yamamoto, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4181 · Cited by 289
Hernández, L., Pinyol, M., Hernández, S., Beà, S., Pulford, K., Rosenwald, A., Lamant, L., Falini, B., Ott, G., Mason, D. Y., et al. (1999) · Blood · doi:10.1182/blood.v94.9.3265 · Cited by 287
Raulo, E., Chernousov, M. A., Carey, D. J., Nolo, R., & Rauvala, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99975-8 · Cited by 284
Maeda, N., Nishiwaki, T., Shintani, T., Hamanaka, H., & Noda, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21446 · Cited by 282
Bai, R.-Y., Dieter, P., Peschel, C., Morris, S. W., & Duyster, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.6951 · Cited by 281
Carén, H., Abel, F., Kogner, P., & Martinsson, T. (2008) · Biochemical Journal · doi:10.1042/bj20081834 · Cited by 280
Fusion of ALK to the Ran‐binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor
Ma, Z., Hill, D. A., Collins, M. H., Morris, S. W., Sumegi, J., Zhou, M., Zuppan, C., & Bridge, J. A. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10177 · Cited by 280
Pathobiology of ALK+ anaplastic large-cell lymphoma
Amin, H. M., & Lai, R. (2007) · Blood · doi:10.1182/blood-2007-04-060715 · Cited by 267
Zhang, Q., Raghunath, P. N., Xue, L., Majewski, M., Carpentieri, D. F., Odum, N., Morris, S., Skorski, T., & Wasik, M. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.466 · Cited by 262
Słupianek, A., Nieborowska-Skorska, M., Hoser, G., Morrione, A., Majewski, M., Xue, L., Morris, S. W., Wasik, M. A., & Skórski, T. (2001) · PubMed · Cited by 258
Molecular cloning of the 18-kDa growth-associated protein of developing brain.
Merenmies, J., & Rauvala, H. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44817-4 · Cited by 256
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors
Chiarle, R., Gong, J. Z., Guasparri, I., Pesci, A., Cai, J., Liu, J., Simmons, W. J., Dhall, G., Howes, J., Piva, R., et al. (2003) · Blood · doi:10.1182/blood-2002-05-1343 · Cited by 252
EML4-ALK Fusion Lung Cancer: A Rare Acquired Event
Perner, S., Wagner, P. L., Demichelis, F., Mehra, R., LaFargue, C. J., Moss, B. J., Arbogast, S., Soltermann, A., Weder, W., Giordano, T. J., et al. (2008) · Neoplasia · doi:10.1593/neo.07878 · Cited by 249
Shiota, M., Fujimoto, J., Semba, T., Satoh, H., Yamamoto, T. S., & Mori, S. (1994) · PubMed · Cited by 246
An SCF-like ubiquitin ligase complex that controls presynaptic differentiation
Liao, E. H., Hung, W., Abrams, B., & Zhen, M. (2004) · Nature · doi:10.1038/nature02647 · Cited by 233
Anaplastic lymphoma kinase proteins in growth control and cancer
Pulford, K., Morris, S. W., & Turturro, F. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.10472 · Cited by 227
Expression of the ALK Tyrosine Kinase Gene in Neuroblastoma
Lamant, L., Pulford, K., Bischof, D., Morris, S. W., Mason, D. Y., Delsol, G., & Mariamé, B. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65042-0 · Cited by 226
The Structure and Functions of NPM1/Nucleophsmin/B23, a Multifunctional Nucleolar Acidic Protein
Okuwaki, M. (2007) · Journal of Biochemistry · doi:10.1093/jb/mvm222 · Cited by 215
Lamant, L., Reyniès, A. D., Duplantier, M.-M., Rickman, D. S., Sabourdy, F., Giuriato, S., Brugières, L., Gaulard, P., Espinos, E., & Delsol, G. (2007) · Blood · doi:10.1182/blood-2006-06-028969 · Cited by 203
Vega, F., Medeiros, L. J., Leventaki, V., Atwell, C., Cho-Vega, J. H., Tian, L., Claret, F.-X., & Rassidakis, G. Z. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3018 · Cited by 196
Jelly belly protein activates the receptor tyrosine kinase Alk to specify visceral muscle pioneers
Lee, H.-H., Norris, A., Weiss, J. B., & Frasch, M. (2003) · Nature · doi:10.1038/nature01916 · Cited by 194
ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma
De Paepe, P., Baens, M., van Krieken, H., Verhasselt, B., Stul, M., Simons, A., Poppe, B., Laureys, G., Brons, P., Vandenberghe, P., et al. (2003) · Blood · doi:10.1182/blood-2003-04-1050 · Cited by 191
Bilsland, J. G., Wheeldon, A., Mead, A., Znamenskiy, P., Almond, S., Waters, K. A., Thakur, M., Beaumont, V., Bonnert, T. P., Heavens, R., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301446 · Cited by 188
Pleiotrophin Signaling through Anaplastic Lymphoma Kinase Is Rate-limiting for Glioblastoma Growth
Powers, C., Aigner, A., Stoica, G. E., McDonnell, K., & Wellstein, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112354200 · Cited by 183
Ishihara, T., Iino, Y., Mohri, A., Mori, I., Gengyo-Ando, K., Mitani, S., & Katsura, I. (2002) · Cell · doi:10.1016/s0092-8674(02)00748-1 · Cited by 182
Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion
Englund, C., Lorén, C. E., Grabbe, C., Varshney, G. K., Deleuil, F., Hallberg, B., & Palmer, R. H. (2003) · Nature · doi:10.1038/nature01950 · Cited by 179
Self-citationHan, Y., Amin, H. M., Franko, B., Frantz, C., Shi, X., & Lai, R. (2006) · Blood · doi:10.1182/blood-2006-04-017434 · Cited by 179
Three-dimensional structure of a cysteine-rich repeat from the low-density lipoprotein receptor.
Daly, N. L., Scanlon, M. J., Djordjevic, J. T., Kroon, P. A., & Smith, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6334 · Cited by 178
Characterization of the expression of the ALK receptor tyrosine kinase in mice
Vernersson, E., Khoo, N. K. S., Henriksson, M. L., Roos, G., Palmer, R. H., & Hallberg, B. (2006) · Gene Expression Patterns · doi:10.1016/j.modgep.2005.11.006 · Cited by 178
Self-citationTomomura, M., Kadomatsu, K., Matsubara, S., & Muramatsu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)87013-2 · Cited by 175
An adhesive domain detected in functionally diverse receptors
Beckmann, G., & Bork, P. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90049-s · Cited by 175
Colleoni, G. W. B., Bridge, J. A., Garicochea, B., Liu, J., Filippa, D. A., & Ladanyi, M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64945-0 · Cited by 174
Amin, H. M., McDonnell, T. J., Ma, Y., Lin, Q., Fujio, Y., Kunisada, K., Leventaki, V., Das, P., Rassidakis, G. Z., Cutler, C., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207703 · Cited by 173
Pérez‐Piñera, P., Zhang, W., Chang, Y., Vega, J. A., & Deuel, T. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704505200 · Cited by 167
ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth
Motegi, A., Fujimoto, J., Kotani, M., Sakuraba, H., & Yamamoto, T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01183 · Cited by 167
LDL Receptor-Related Protein as a Component of the Midkine Receptor
Muramatsu, H., Zou, K., Sakaguchi, N., Ikematsu, S., Sakuma, S., & Muramatsu, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2549 · Cited by 167
Shinmura, K., Kageyama, S., Tao, H., Bunai, T., Suzuki, M., Kamo, T., Takamochi, K., Suzuki, K., Tanahashi, M., Niwa, H., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2007.12.013 · Cited by 164
Leukocyte Tyrosine Kinase Functions in Pigment Cell Development
Lopes, S. S., Yang, X., Müller, J., Carney, T. J., McAdow, A. R., Rauch, G.-J., Jacoby, A. S., Hurst, L. D., Delfino-Machín, M., Haffter, P., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000026 · Cited by 163
Debelenko, L. V., Arthur, D. C., Pack, S. D., Helman, L. J., Schrump, D. S., & Tsokos, M. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000088856.49388.ea · Cited by 163
Piva, R., Pellegrino, E., Mattioli, M., Agnelli, L., Lombardi, L., Boccalatte, F., Costa, G., Ruggeri, B. A., Cheng, M., Chiarle, R., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29401 · Cited by 163
Bazigou, E., Apitz, H., Johansson, J., Lorén, C. E., Hirst, E. M. A., Chen, P.-L., Palmer, R. H., & Salecker, I. (2007) · Cell · doi:10.1016/j.cell.2007.02.024 · Cited by 161
Self-citationBiological Role of Anaplastic Lymphoma Kinase in Neuroblastoma
Osajima-Hakomori, Y., Miyake, I., Ohira, M., Nakagawara, A., Nakagawa, A., & Sakai, R. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62966-5 · Cited by 159
Moog-Lutz, C., Degoutin, J., Gouzi, J. Y., Frobert, Y., Carvalho, N. B.-D., Bureau, J., Créminon, C., & Vigny, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501972200 · Cited by 158
TAKAHASHI, I., Saitoh, Y., Yoshida, M., Sano, H., Nakano, H., Morimoto, M., & Tamaoki, T. (1989) · The Journal of Antibiotics · doi:10.7164/antibiotics.42.571 · Cited by 158
Development of anaplastic lymphoma kinase (ALK) small‐molecule inhibitors for cancer therapy
Li, R., & Morris, S. W. (2007) · Medicinal Research Reviews · doi:10.1002/med.20109 · Cited by 148
α4β1- and α6β1-integrins are functional receptors for midkine, a heparin-binding growth factor
Muramatsu, H., Zou, P., Suzuki, H., Oda, Y., Chen, G., Sakaguchi, N., Sakuma, S., Maeda, N., Noda, M., Takada, Y., et al. (2004) · Journal of Cell Science · doi:10.1242/jcs.01423 · Cited by 147
Nakamura, E., Kadomatsu, K., Yuasa, S., Muramatsu, H., Mamiya, T., NABESHIMA, T., Fan, Q., Ishiguro, K., Igakura, T., Matsubara, S., et al. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00231.x · Cited by 144
Amin, H. M., Medeiros, L. J., Ma, Y., Feretzaki, M., Das, P., Leventaki, V., Rassidakis, G. Z., O’Connor, S. L., McDonnell, T. J., & Lai, R. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206849 · Cited by 142
Jazii, F. R. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i44.7104 · Cited by 141
Zhang, Q., Wang, H. Y., Liu, X., & Wasik, M. A. (2007) · Nature Medicine · doi:10.1038/nm1659 · Cited by 141
Non‐muscle myosin heavy chain (MYH9): A new partner fused to ALK in anaplastic large cell lymphoma
Lamant, L., Gascoyne, R. D., Duplantier, M.-M., Armstrong, F., Raghab, A., Chhanabhai, M., Rajcan‐Separovic, E., Raghab, J., Delsol, G., & Espinos, E. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10232 · Cited by 141
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas
Piva, R., Chiarle, R., Manazza, A. D., Taulli, R., Simmons, W. R., Ambrogio, C., d’Escamard, V., Pellegrino, E., Ponzetto, C., Palestro, G., et al. (2005) · Blood · doi:10.1182/blood-2005-05-2125 · Cited by 138
Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma
Du, X., Hu, H., Lin, D., Xia, S.-H., Shen, X., Zhang, Y., Luo, M., Feng, Y., Cai, Y., Xu, X., et al. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0159-4 · Cited by 136
Mourali, J., Bénard, A., Lourenço, F. C., Monnet, C., Greenland, C., Moog‐Lutz, C., Racaud‐Sultan, C., Gonzalez‐Dunia, D., Vigny, M., Mehlen, P., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01515-05 · Cited by 134
Differential Induction of Glioblastoma Migration and Growth by Two Forms of Pleiotrophin
Lu, K. V., Jong, K. A., Kim, G., Singh, J., Dia, E. Q., Yoshimoto, K., Wang, M. Y., Cloughesy, T. F., Nelson, S. F., & Mischel, P. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502614200 · Cited by 133
Souttou, B., Carvalho, N. B.-D., Raulais, D., & Vigny, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007333200 · Cited by 133
Bonvini, P., Gastaldi, T., Falini, B., & Rosolen, A. (2002) · PubMed · Cited by 130
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination
Chiarle, R., Martinengo, C., Mastini, C., Ambrogio, C., d’Escamard, V., Forni, G., & Inghirami, G. (2008) · Nature Medicine · doi:10.1038/nm1769 · Cited by 129
Armstrong, F., Duplantier, M.-M., Trempat, P., Hiéblot, C., Lamant, L., Espinos, E., Racaud‐Sultan, C., Allouche, M., Campo, E., Delsol, G., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207813 · Cited by 129
Gu, T., Tóthová, Z., Scheijen, B., Griffin, J. D., Gilliland, D. G., & Sternberg, D. (2004) · Blood · doi:10.1182/blood-2003-03-0820 · Cited by 127
Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor
Panagopoulos, I., Nilsson, T., Domanski, H. A., Isaksson, M., Lindblom, P., Mertens, F., & Mandahl, N. (2005) · International Journal of Cancer · doi:10.1002/ijc.21490 · Cited by 126
Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines
Dirks, W. G., Fähnrich, S., Lis, Y., Becker, E., MacLeod, R. A. F., & Drexler, H. G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10435 · Cited by 125
Lorén, C. E., Englund, C., Grabbe, C., Hallberg, B., Hunter, T. R., & Palmer, R. H. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor897 · Cited by 123
Self-citationMitogenic properties of a new endothelial cell growth factor related to pleiotrophin
Courty, J., Dauchel, M. C., Caruelle, D., Perderiset, M., & Barritault, D. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81267-7 · Cited by 123
Tezuka, K.-I., Takeshita, S., Hakeda, Y., Kumegawa, M., Kikuno, R. F., & Hashimoto-Gotoh, T. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81048-4 · Cited by 123
ten Berge, R. L., Meijer, C. J. L. M., Dukers, D. F., Kummer, J. A., Bladergroen, B. A., Vos, W., Hack, C. E., Ossenkoppele, G. J., & Oudejans, J. J. (2002) · Blood · doi:10.1182/blood.v99.12.4540 · Cited by 121
Vanderwinden, J., Mailleux, P., Schiffmann, S. N., & Vanderhaeghen, J. J. (1992) · Anatomy and Embryology · doi:10.1007/bf00185989 · Cited by 118
Nieborowska-Skorska, M., Słupianek, A., Xue, L., Zhang, Q., Raghunath, P. N., Hoser, G., Wasik, M. A., Morris, S. W., & Skórski, T. (2001) · PubMed · Cited by 116
Kilpeläinen, I., Kaksonen, M., Kinnunen, T. K., Avikainen, H., Fath, M. A., Linhardt, R. J., Raulo, E., & Rauvala, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13564 · Cited by 116
Miyake, I., Hakomori, Y., Shinohara, A., Gamou, T., Saito, M., Iwamatsu, A., & Sakai, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205735 · Cited by 116
Identification of NPM-ALK interacting proteins by tandem mass spectrometry
Crockett, D. K., Lin, Z., Elenitoba‐Johnson, K. S. J., & Lim, M. S. (2004) · Oncogene · doi:10.1038/sj.onc.1207398 · Cited by 113
Marzec, M., Kasprzycka, M., Liu, X., El-Salem, M., Halasa, K., Raghunath, P. N., Bucki, R., Wlodarski, P. K., & Wasik, M. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210346 · Cited by 113
Lorén, C. E., Scully, A. L., Grabbe, C., Edeen, P. T., Thomas, J. B., McKeown, M., Hunter, T. R., & Palmer, R. H. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00440.x · Cited by 111
Self-citationWan, W., Albom, M. S., Lü, L., Quail, M. R., Becknell, N. C., Weinberg, L. R., Reddy, D. R., Holskin, B. P., Angeles, T. S., Underiner, T. L., et al. (2005) · Blood · doi:10.1182/blood-2005-08-3254 · Cited by 111
Khoury, J. D., Medeiros, L. J., Rassidakis, G. Z., Yared, M. A., Tsioli, P., Leventaki, V., Schmitt-Graeff, A. H., Herling, M., Amin, H. M., & Lai, R. L. (2003) · PubMed · Cited by 110
Diversity of Genomic Breakpoints in TFG-ALK Translocations in Anaplastic Large Cell Lymphomas
Hernández, L., Beà, S., Bellosillo, B., Pinyol, M., Falini, B., Carbone, A., Ott, G., Rosenwald, A., Fernández, A., Pulford, K. A. F., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62574-6 · Cited by 107
Sonic Hedgehog Signaling Pathway Is Activated in ALK-Positive Anaplastic Large Cell Lymphoma
Singh, R. R., Cho‐Vega, J. H., Davuluri, Y., Ma, S., Kasbidi, F., Milito, C. B., Lennon, P. A., Drakos, E., Medeiros, L. J., Luthra, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1808 · Cited by 104
Voena, C., Conte, C., Ambrogio, C., Erba, E. B., Boccalatte, F. E., Mohammed, S., Jensen, O. N., Palestro, G., Inghirami, G., & Chiarle, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4350 · Cited by 103
Anti-apoptotic Signaling of Pleiotrophin through Its Receptor, Anaplastic Lymphoma Kinase
Bowden, E. T., Stoica, G. E., & Wellstein, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203963200 · Cited by 102
The NPM-ALK and the ATIC-ALK Fusion Genes Can Be Detected in Non-Neoplastic Cells
Maes, B., Vanhentenrijk, V., Włodarska, I., Cools, J., Peeters, B., Marynen, P., & Wolf‐Peeters, C. D. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64690-1 · Cited by 101
Nakanishi, T., Kadomatsu, K., Okamoto, T., Ichihara-Tanaka, K., Kojima, T., Saito, H., Tomoda, Y., & Muramatsu, T. (1997) · PubMed · Cited by 98
Marzec, M., Kasprzycka, M., Liu, X., Raghunath, P. N., Wlodarski, P. K., & Wasik, M. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209843 · Cited by 96
Leventaki, V., Drakos, E., Medeiros, L. J., Lim, M. S., Elenitoba‐Johnson, K. S. J., Claret, F. X., & Rassidakis, G. Z. (2007) · Blood · doi:10.1182/blood-2006-11-059451 · Cited by 95
Weiss, J. B., Suyama, K. L., Lee, H., & Scott, M. P. (2001) · Cell · doi:10.1016/s0092-8674(01)00540-2 · Cited by 91
Bernards, A., & de la Monte, S. M. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07399.x · Cited by 89
Trümper, Pfreundschuh, Bonin, & Daus (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01097.x · Cited by 88
NIPA Defines an SCF-Type Mammalian E3 Ligase that Regulates Mitotic Entry
Bassermann, F. C., von Klitzing, C., Münch, S., Bai, R.-Y., Kawaguchi, H., Morris, S. W., Peschel, C., & Duyster, J. (2005) · Cell · doi:10.1016/j.cell.2005.04.034 · Cited by 84
Tartari, C. J., Gunby, R. H., Coluccia, A. M. L., Sottocornola, R., Cimbro, B., Scapozza, L., Donella‐Deana, A., Pinna, L. A., & Gambacorti-Passerini, C. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706067200 · Cited by 84
Human Breast Cancer Growth Inhibited in Vivo by a Dominant Negative Pleiotrophin Mutant
Zhang, N., Zhong, R., Wang, Z., & Deuel, T. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.16733 · Cited by 83
Qiu, L., Lai, R. L., Lin, Q. D., et al. (2006) · Blood · doi:10.1182/blood-2006-04-020305 · Cited by 82
Muramatsu, H., Zou, P., Kurosawa, N., Ichihara-Tanaka, K., Maruyama, K., Inoh, K., Sakai, T., Chen, L., Sato, M., & Muramatsu, T. (2006) · Genes to Cells · doi:10.1111/j.1365-2443.2006.01028.x · Cited by 82
Reiner, D. J., Ailion, M., Thomas, J. H., & Meyer, B. J. (2008) · Current Biology · doi:10.1016/j.cub.2008.06.060 · Cited by 82
Shi, X., Franko, B., Frantz, C., Amin, H. M., & Lai, R. L. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06259.x · Cited by 80
Overexpression of NPM–ALK induces different types of malignant lymphomas in IL-9 transgenic mice
de Lange, K., Uckert, W., Blankenstein, T. J. F., Nadrowitz, R., Bittner, C., Renauld, J., Snick, J. V., Feller, A. C., & Merz, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206076 · Cited by 74
Klapper, R., Stute, C., Schomaker, O., Strasser, T., Janning, W., Renkawitz‐Pohl, R., & Holz, A. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00567-6 · Cited by 73
Stute, C., Schimmelpfeng, K., Renkawitz‐Pohl, R., Palmer, R. H., & Holz, A. (2004) · Development · doi:10.1242/dev.00972 · Cited by 73
Self-citationMarzec, M., Kasprzycka, M., Ptasznik, A., Wlodarski, P. K., Zhang, Q., Ødum, N., & Wasik, M. A. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700348 · Cited by 73
Colomba, A., Courilleau, D., Ramel, D., Billadeau, D. D., Espinos, E., Delsol, G., Payrastre, B., & Gaits‐Iacovoni, F. (2007) · Oncogene · doi:10.1038/sj.onc.1210921 · Cited by 71
Hurley, S. P., Clary, D. O., Copié, V., & Lefcort, F. B. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20887 · Cited by 70
Turner, S. D., Tooze, R. M., MacLennan, K., & Alexander, D. R. (2003) · Oncogene · doi:10.1038/sj.onc.1207048 · Cited by 69
Grzelinski, M., Steinberg, F., Martens, T., Czubayko, F., Lamszus, K., & Aigner, A. M. (2009) · Neoplasia · doi:10.1593/neo.81040 · Cited by 68
Kovesdi, I., Fairhurst, J. L., Kretschmer, P. J., & Böhlen, P. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90753-a · Cited by 68
Martin, B. S., Ruiz‐Gómez, M., Landgraf, M., & Bate, M. (2001) · Development · doi:10.1242/dev.128.17.3331 · Cited by 68
Khoury, J. D., Rassidakis, G. Z., Medeiros, L. J., Amin, H. M., & Lai, R. L. (2004) · Blood · doi:10.1182/blood-2004-03-1151 · Cited by 66
Mathivet, T., Mazot, P., & Vigny, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.07.011 · Cited by 65
Ambrogio, C., Voena, C., Manazza, A. D., Martinengo, C., Costa, C., Kirchhausen, T. L., Hirsch, E., Inghirami, G., & Chiarle, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2568 · Cited by 65
Kuo, A. H., Stoica, G. E., Riegel, A. T., & Wellstein, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209840 · Cited by 64
Donella‐Deana, A., Marin, O., Cesaro, L., Gunby, R. H., Ferrarese, A., Coluccia, A. M. L., Tartari, C. J., Mologni, L., Scapozza, L., Gambacorti-Passerini, C. B., et al. (2005) · Biochemistry · doi:10.1021/bi0472954 · Cited by 64
EML4–ALK fusion transcript is not found in gastrointestinal and breast cancers
Fukuyoshi, Y., Inoue, H., Kita, Y., Utsunomiya, T., Ishida, T., & Mori, M. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604341 · Cited by 63
Ouyang, T., Bai, R.-Y., Bassermann, F. C., von Klitzing, C., Klümpen, S., Miething, C., Morris, S. W., Peschel, C., & Duyster, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300883200 · Cited by 57
Degoutin, J. L., Carvalho, N. B.-D., Cifuentes-Díaz, C., & Vigny, M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06593.x · Cited by 57
Design and Synthesis of 5-Aryl-pyridone-carboxamides as Inhibitors of Anaplastic Lymphoma Kinase
Li, R., Xue, L., Zhu, T., Jiang, Q. L., Cui, X., Yan, Z., McGee, D. P. C., Wang, J., Gantla, V. R., Pickens, J. C., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050824x · Cited by 55
Siebert, R., Gesk, S., Harder, L., et al. (1999) · PubMed · doi:10.1182/blood.v94.10.3614.422a38e_3614_3617 · Cited by 49
Herradón, G., Ezquerra, L., Nguyen, T. T. T., Silos‐Santiago, I., & Deuel, T. F. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.160 · Cited by 46
Gouzi, J. Y., Moog‐Lutz, C., Vigny, M., & Carvalho, N. B.-D. (2005) · Journal of Cell Science · doi:10.1242/jcs.02695 · Cited by 46
Zou, P., Muramatsu, H., Sone, M., et al. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700428 · Cited by 43
Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphoma
Lai, R., Rassidakis, G. Z., LIN, Q., Atwell, C., Medeiros, L. J., & Amin, H. M. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.07.011 · Cited by 42
Yang, H., Eriksson, T., Vernersson, E., et al. (2007) · Journal of Experimental Zoology Part B Molecular and Developmental Evolution · doi:10.1002/jez.b.21146 · Cited by 41
Self-citationThe potential role of the heparin-binding growth factor pleiotrophin in breast cancer
Riegel, A. T., & Wellstein, A. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666163 · Cited by 39
Hyperactivated STAT3 in ALK–positive diffuse large B-cell lymphoma with clathrin-ALK fusion
Momose, S., Tamaru, J., Kishi, H., Mikata, I., Mori, M., Toyozumi, Y., & Itoyama, S. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.06.009 · Cited by 39
The bHLH transcription factor Hand is regulated by Alk in the Drosophila embryonic gut
Varshney, G. K., & Palmer, R. H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.117 · Cited by 38
Self-citationLocalization of pleiotrophin and midkine in the postnatal developing cerebellum
Matsumoto, K., Wanaka, A., Mori, T., Taguchi, A., Ishii, N., Muramatsu, H., Muramatsu, T., & Tohyama, M. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90762-5 · Cited by 36
Ribozyme‐targeting reveals the rate‐limiting role of pleiotrophin in glioblastoma
Grzelinski, M., Bader, N., Czubayko, F., & Aigner, A. M. (2005) · International Journal of Cancer · doi:10.1002/ijc.21276 · Cited by 35
Fan, Q., Muramatsu, T., & Kadomatsu, K. (2000) · Development Growth & Differentiation · doi:10.1046/j.1440-169x.2000.00497.x · Cited by 33
Drosophila Anaplastic Lymphoma Kinase regulates Dpp signalling in the developing embryonic gut
Shirinian, M., Varshney, G. K., Lorén, C. E., Grabbe, C., & Palmer, R. H. (2007) · Differentiation · doi:10.1111/j.1432-0436.2006.00148.x · Cited by 31
Self-citationGunby, R. H., Tartari, C. J., Porchia, F., Donella‐Deana, A., Scapozza, L., & Gambacorti-Passerini, C. B. (2005) · PubMed · Cited by 18
Cited by
Camidge, D. R., Bang, Y.-J., Kwak, E. L., Iafrate, A. J., Varella-Garcia, M., Fox, S. B., Riely, G. J., Solomon, B., Ou, S.-H. I., Kim, D.-W., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70344-3 · Cited by 1,268
Cui, J. J., Tran-Dubé, M., Shen, H., Nambu, M., Kung, P.-P., Pairish, M., Jia, L., Meng, J., Funk, L., Botrous, I., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2007613 · Cited by 932
Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor
Butrynski, J. E., D'Adamo, D. R., Hornick, J. L., Dal Cin, P., Antonescu, C. R., Jhanwar, S. C., Ladanyi, M., Capelletti, M., Rodig, S. J., Ramaiya, N., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007056 · Cited by 870
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Hallberg, B., & Palmer, R. H. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3580 · Cited by 645
Self-citationWalker, A. J., Majzner, R. G., Zhang, L., Wanhainen, K., Long, A. H., Nguyen, S. M., Lopomo, P., Vigny, M., Fry, T. J., Orentas, R. J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.06.008 · Cited by 383
Metadata
- Authors
- Palmer, R. H., Vernersson, E., Grabbe, C., & Hallberg, B.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2009-05-27
- Volume
- 420
- Issue
- 3
- Pages
- 345-361
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W1969914656
- Cited by
- 423
- References
- 189
- FWCI
- 34.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.